{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:09:30Z","timestamp":1790788170792,"version":"4.1.0"},"reference-count":84,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Increasing potassium intake ameliorates blood pressure (BP) and cardiovascular (CV) prognoses in the general population; therefore the World Health Organization recommends a high-potassium diet (90\u2013120 mEq\/day). Hyperkalaemia is a rare condition in healthy individuals due to the ability of the kidneys to effectively excrete dietary potassium load in urine, while an increase in serum K+ is prevalent in patients with chronic kidney disease (CKD). Hyperkalaemia prevalence increases in more advanced CKD stages, and is associated with a poor prognosis. This scenario generates controversy on the correct nutritional approach to hyperkalaemia in CKD patients, considering the unproven link between potassium intake and serum K+ levels. Another concern is that drug-induced hyperkalaemia leads to the down-titration or withdrawal of renin-angiotensin system inhibitors (RASI) and mineralocorticoids receptors antagonists (MRA) in patients with CKD, depriving these patients of central therapeutic interventions aimed at delaying CKD progression and decreasing CV mortality. The new K+-binder drugs (Patiromer and Sodium-Zirconium Cyclosilicate) have proven to be adequate and safe therapeutic options to control serum K+ in CKD patients, enabling RASI and MRA therapy, and possibly, a more liberal intake of fruit and vegetables.<\/jats:p>","DOI":"10.3390\/ijms23126378","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T02:25:33Z","timestamp":1654827933000},"page":"6378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-4597","authenticated-orcid":false,"given":"Silvio","family":"Borrelli","sequence":"first","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Matarazzo","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Lembo","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Peccarino","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Annoiato","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Scognamiglio","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Foderini","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5437-5711","authenticated-orcid":false,"given":"Chiara","family":"Ruotolo","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0730-9054","authenticated-orcid":false,"given":"Aldo","family":"Franculli","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Capozzi","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Yavorskiy","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatme","family":"Merheb","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-702X","authenticated-orcid":false,"given":"Michele","family":"Provenzano","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Transplant Unit of the University of Bologna \u201cAlma Mater Studiorum\u201d, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Transplant Unit of the University of Bologna \u201cAlma Mater Studiorum\u201d, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8532-0182","authenticated-orcid":false,"given":"Luca","family":"De Nicola","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Minutolo","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Garofalo","sequence":"additional","affiliation":[{"name":"Silvio Borrelli Unit, Nephrology Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d Piazza Miraglia, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Clase","year":"2020","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2109794","article-title":"24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk","volume":"386","author":"Ma","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa2105675","article-title":"Salt Substitute and Cardiovascular Events and Death. Reply","volume":"385","author":"Neal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: A CKD Prognosis Consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Regulation of Potassium Homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin. J. Am. Soc Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMra1313341","article-title":"An Integrated View of Potassium Homeostasis","volume":"373","author":"Gumz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1152\/physrev.00044.2018","article-title":"Regulation of the Renal NaCl Cotransporter and Its Role in Potassium Homeostasis","volume":"100","author":"Hoorn","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cmet.2014.12.006","article-title":"Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride","volume":"21","author":"Terker","year":"2015","journal-title":"Cell Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"BSR20171243","DOI":"10.1042\/BSR20171243","article-title":"Role of ClC-K and barttin in low potassium-induced sodium chloride cotransporter activation and hypertension in mouse kidney","volume":"38","author":"Nomura","year":"2018","journal-title":"Biosci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1113\/JP272311","article-title":"SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule","volume":"594","author":"Ferdaus","year":"2016","journal-title":"J. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"F643","DOI":"10.1152\/ajprenal.00460.2017","article-title":"Renal potassium handling in rats with subtotal nephrectomy: Odelling and analysis","volume":"314","author":"Layton","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1681\/ASN.2017030295","article-title":"Sexual Dimorphic Pattern of Renal Transporters and Electrolyte Homeostasis","volume":"28","author":"Veiras","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2017.01.044","article-title":"Race, Serum Potassium, and Associations with ESRD and Mortality","volume":"70","author":"Chen","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.116.07363","article-title":"Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System","volume":"67","author":"Chang","year":"2016","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20543581211017408","DOI":"10.1177\/20543581211017408","article-title":"Initial and Recurrent Hyperkalemia Events in Patients with CKD in Older Adults: A Population-Based Cohort Study","volume":"8","author":"Sriperumbuduri","year":"2021","journal-title":"Can. J. Kidney Health Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1532-5415.2011.03818.x","article-title":"Metabolic complications in elderly adults with chronic kidney disease","volume":"60","author":"Drawz","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_17","first-page":"c8","article-title":"Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: The role of race","volume":"120","author":"Hayes","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic","volume":"7","author":"Sarafidis","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000437151","article-title":"Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease","volume":"41","author":"Nakhoul","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/03007995.2018.1433141","article-title":"The prevalence of hyperkalemia in the United States","volume":"34","author":"Betts","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and\/or Diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.030576","article-title":"Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality","volume":"137","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Provenzano, M., Minutolo, R., Chiodini, P., Bellizzi, V., Nappi, F., Russo, D., Borrelli, S., Garofalo, C., Iodice, C., and De Stefano, T. (2018). Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care. J. Clin. Med., 7.","DOI":"10.20944\/preprints201811.0170.v1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/ndt\/gfaa232","article-title":"Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?","volume":"36","author":"Ramos","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10157-020-02010-7","article-title":"Association between serum potassium levels and adverse outcomes in chronic kidney disease: The Fukushima CKD cohort study","volume":"25","author":"Tanaka","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11739-020-02353-9","article-title":"Prevalence and correlates of hyperkalemia in a renal nutrition clinic","volume":"16","author":"Cumetti","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11739-021-02653-8","article-title":"Epidemiology of hyperkalemia in CKD patients under nephrological care: A longitudinal study","volume":"16","author":"Panuccio","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e13475","DOI":"10.1111\/ijcp.13475","article-title":"Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy","volume":"74","author":"Provenzano","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamacardio.2019.0640","article-title":"Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia from the Electrocardiogram","volume":"4","author":"Galloway","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/j.ajkd.2018.06.010","article-title":"Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report","volume":"72","author":"Weir","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamainternmed.2020.0193","article-title":"Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons with Low Estimated Glomerular Filtration Rate","volume":"180","author":"Qiao","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40620-021-01070-6","article-title":"Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease","volume":"35","author":"Santoro","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Leon, S.J., Whitlock, R., Rigatto, C., Komenda, P., Bohm, C., Sucha, E., Bota, S.E., Tuna, M., Collister, D., and Sood, M. (2022). Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study. Am. J. Kidney Dis., in press.","DOI":"10.1053\/j.ajkd.2022.01.002"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2021.09.010","article-title":"KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD","volume":"79","author":"Mottl","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e011716","DOI":"10.1136\/bmjopen-2016-011716","article-title":"Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine","volume":"6","author":"Cappuccio","year":"2016","journal-title":"BMJ Open"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gritter, M., Wouda, R., Yeung, S., Wieers, M., Geurts, F., de Ridder, M., Ramakers, C., Vogt, L., de Borst, M., and Rotmans, J. (2022). Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease. J. Am. Soc. Nephrol., ASN.2022020147.","DOI":"10.1681\/ASN.2022020147"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional Management of Chronic Kidney Disease","volume":"377","author":"Fouque","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Borrelli, S., De Nicola, L., Minutolo, R., Conte, G., Chiodini, P., Cupisti, A., Santoro, D., Calabrese, V., Giannese, D., and Garofalo, C. (2021). Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care. Nutrients, 13.","DOI":"10.3390\/nu13030942"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2215\/CJN.08360621","article-title":"Dietary Potassium Intake and All-Cause Mortality in Adults Treated with Hemodialysis","volume":"16","author":"Wong","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.ajkd.2010.03.022","article-title":"Dietary potassium intake and mortality in long-term hemodialysis patients","volume":"56","author":"Noori","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.jrn.2016.02.005","article-title":"Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients?","volume":"26","author":"Goldfarb","year":"2016","journal-title":"J. Renal Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.1750","article-title":"Enhanced large intestinal potassium permeability in end-stage renal disease","volume":"206","author":"Mathialahan","year":"2005","journal-title":"J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1681\/ASN.2015010022","article-title":"Chronic Renal Insufficiency Cohort Study Investigators. Urinary Sodium and Potassium Excretion and CKD Progression","volume":"27","author":"He","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2215\/CJN.07820618","article-title":"KNOW-CKD Study Investigators. Urinary Potassium Excretion and Progression of CKD","volume":"14","author":"Kim","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2215\/CJN.12391018","article-title":"Plant-Based Diets and Incident CKD and Kidney Function","volume":"14","author":"Kim","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2019.02.023","article-title":"A Diet Rich in Vegetables and Fruit and Incident CKD: A Community-Based Prospective Cohort Study","volume":"74","author":"Jhee","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2215\/CJN.06190616","article-title":"Healthy Dietary Patterns and Risk of Mortality and ESRD in CKD: A Meta-Analysis of Cohort Studies","volume":"12","author":"Kelly","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000514754","article-title":"Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption","volume":"52","author":"Banerjee","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2020.04.019","article-title":"Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings from the CRIC (Chronic Renal Insufficiency Cohort) Study","volume":"77","author":"Hu","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Cupisti, A., Kovesdy, C.P., D\u2019Alessandro, C., and Kalantar-Zadeh, K. (2018). Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function. Nutrients, 10.","DOI":"10.3390\/nu10030261"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","article-title":"Plant-based diets to manage the risks and complications of chronic kidney disease","volume":"16","author":"Carrero","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ki.2011.355","article-title":"High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease","volume":"81","author":"Krishnamurthy","year":"2012","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2215\/CJN.02430312","article-title":"A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate","volume":"8","author":"Goraya","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2215\/CJN.09660721","article-title":"Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet? A Cautionary Tale","volume":"17","author":"Clegg","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","article-title":"Clinical Management of Hyperkalemia","volume":"96","author":"Palmer","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamainternmed.2019.0631","article-title":"Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age","volume":"179","author":"Noel","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfz150","article-title":"Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: A nationwide study","volume":"35","author":"Laureati","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of Patiromer on Serum Potassium Level in Patients with Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.xkme.2021.01.005","article-title":"Hyperkalemia Management in Older Adults with Diabetic Kidney Disease Receiving Renin-Angiotensin-Aldosterone System Inhibitors: A Post Hoc Analysis of the AMETHYST-DN Clinical Trial","volume":"3","author":"Bakris","year":"2021","journal-title":"Kidney Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): A phase 2, randomised, double-blind, placebo-controlled trial","volume":"394","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"ref_66","unstructured":"(2022, May 05). Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi for HFrEF\u2014DIAMOND. Available online: https:\/\/www.acc.org\/Latest-in-Cardiology\/Clinical-Trials\/2022\/04\/02\/15\/56\/DIAMOND."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"FIDELIO-DKD Investigators. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"FIGARO-DKD Investigators. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"ZS-005 Study Investigators. Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2019050450","article-title":"A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia","volume":"30","author":"Fishbane","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ki.1973.138","article-title":"Potassium deficiency in chronic renal failure","volume":"4","author":"Bilbrey","year":"1973","journal-title":"Kidney Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ki.1977.73","article-title":"Increased large intestinal secretion of potassium in renal insufficiency","volume":"12","author":"Bastl","year":"1977","journal-title":"Kidney Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfu376","article-title":"Ranking of factors determining potassium mass balance in bicarbonate haemodialysis","volume":"30","author":"Basile","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/sdi.12738","article-title":"Dialysate potassium concentration: Should mass balance trump electrophysiology?","volume":"31","author":"Pun","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2010.315","article-title":"Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics","volume":"79","author":"Pun","year":"2011","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ndt\/gfx241","article-title":"Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients","volume":"33","author":"Brunelli","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-1797.2005.00362.x","article-title":"QTc dispersion in haemodialysis patients with cardiac complications","volume":"10","author":"Nakamura","year":"2005","journal-title":"Nephrology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000045387","article-title":"Potassium removal increases the QTc interval dispersion during hemodialysis","volume":"82","author":"Cupisti","year":"1999","journal-title":"Nephron"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ndt\/gfm730","article-title":"Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal","volume":"23","author":"Santoro","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/ndt\/12.8.1629","article-title":"Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium","volume":"12","author":"Blumberg","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1681\/ASN.V11122337","article-title":"Effect of dialysate sodium concentration on interdialytic increase of potassium","volume":"11","author":"Bellizzi","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ki.1990.200","article-title":"Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure","volume":"38","author":"Conte","year":"1990","journal-title":"Kidney Int."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/12\/6378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:25:38Z","timestamp":1760138738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/12\/6378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23126378"],"URL":"https:\/\/doi.org\/10.3390\/ijms23126378","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]}}}